Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study examined the effects of intensive versus standard glycemic control on cardiovascular events in type 2 diabetes patients, finding no significant differences in certain outcomes.
A 12-week laughter yoga program was found to be feasible for individuals with type 2 diabetes and demonstrated improvements in glycemic control.
Switching from premixed insulin to the insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) improved glycemic control in participants with type 2 diabetes.
This study evaluated an educational intervention aimed at improving sleep hygiene in patients with type 2 diabetes, showing significant improvements in sleep quality and metabolic markers at 3 months.
This study evaluated the impact of light therapy on sleep quality and circadian rhythm in older adults with type 2 diabetes, finding significant improvements in sleep quality.
The study evaluated the effectiveness of the PREDIABETEXT digital health intervention for managing prediabetes. It found a nonsignificant reduction in HbA1c levels.
This study evaluated the effects of finerenone on heart and kidney events in patients with chronic kidney disease and type 2 diabetes, finding significant reductions in event rates compared to placebo.
This study evaluated the efficacy and safety of HRS-7535 in adults with type 2 diabetes inadequately controlled with metformin, showing significant reductions in HbA1c and fasting plasma glucose levels.
This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.
This study analyzed the relationship between insulin-like growth factor-1 (IGF-1) levels and cardiovascular outcomes in hyperglycemic acute coronary syndrome patients, finding no independent association with major adverse cardiovascular events.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
